122 related articles for article (PubMed ID: 9627719)
1. Immunotherapy of melanoma.
Mitchell MS
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):215-8. PubMed ID: 9627719
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
[TBL] [Abstract][Full Text] [Related]
3. Perspective on allogeneic melanoma lysates in active specific immunotherapy.
Mitchell MS
Semin Oncol; 1998 Dec; 25(6):623-35. PubMed ID: 9865677
[TBL] [Abstract][Full Text] [Related]
4. Melanoma adjuvant therapy.
Tarhini AA; Thalanayar PM
Hematol Oncol Clin North Am; 2014 Jun; 28(3):471-89. PubMed ID: 24880942
[TBL] [Abstract][Full Text] [Related]
5. Improving survival in patients with high-risk and metastatic melanoma: immunotherapy leads the way.
Agarwala S
Am J Clin Dermatol; 2003; 4(5):333-46. PubMed ID: 12688838
[TBL] [Abstract][Full Text] [Related]
6. Cancer vaccines, a critical review--Part I.
Mitchell MS
Curr Opin Investig Drugs; 2002 Jan; 3(1):140-9. PubMed ID: 12054065
[TBL] [Abstract][Full Text] [Related]
7. Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies.
Kirkwood JM
Eur J Cancer; 1998 Jul; 34 Suppl 3():S12-7. PubMed ID: 9849403
[TBL] [Abstract][Full Text] [Related]
8. New approaches to the systemic treatment of melanoma.
Chowdhury S; Vaughan MM; Gore ME
Cancer Treat Rev; 1999 Oct; 25(5):259-70. PubMed ID: 10544070
[TBL] [Abstract][Full Text] [Related]
9. Melacine: an allogeneic melanoma tumor cell lysate vaccine.
Sosman JA; Sondak VK
Expert Rev Vaccines; 2003 Jun; 2(3):353-68. PubMed ID: 12903801
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of malignant melanoma.
Kadison AS; Morton DL
Surg Clin North Am; 2003 Apr; 83(2):343-70. PubMed ID: 12744613
[TBL] [Abstract][Full Text] [Related]
11. The treatment of melanoma with an emphasis on immunotherapeutic strategies.
Jack A; Boyes C; Aydin N; Alam K; Wallack M
Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.
Keilholz U; Stoter G; Punt CJ; Scheibenbogen C; Lejeune F; Eggermont AM
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S22-8. PubMed ID: 9457389
[TBL] [Abstract][Full Text] [Related]
13. Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma.
Morton DL
Dev Biol (Basel); 2004; 116():209-17; discussion 229-36. PubMed ID: 15603194
[TBL] [Abstract][Full Text] [Related]
14. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
Berinstein NL
Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
[TBL] [Abstract][Full Text] [Related]
15. The current EORTC Melanoma Cooperative Group adjuvant trial programme on malignant melanoma: prognosis versus efficacy, toxicity and costs.
Eggermont AM
Melanoma Res; 1997 Aug; 7 Suppl 2():S127-31. PubMed ID: 9578428
[TBL] [Abstract][Full Text] [Related]
16. Melanoma and immunotherapy.
Eggermont AM; Schadendorf D
Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
[TBL] [Abstract][Full Text] [Related]
17. Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.
Dillman RO; Cornforth AN; Depriest C; McClay EF; Amatruda TT; de Leon C; Ellis RE; Mayorga C; Carbonell D; Cubellis JM
J Immunother; 2012 Oct; 35(8):641-9. PubMed ID: 22996370
[TBL] [Abstract][Full Text] [Related]
18. Biochemotherapy of melanoma.
Keilholz U
Forum (Genova); 2003; 13(2):158-65; quiz 189. PubMed ID: 14732882
[TBL] [Abstract][Full Text] [Related]
19. Vaccine therapy for patients with melanoma.
Haigh PI; Difronzo LA; Gammon G; Morton DL
Oncology (Williston Park); 1999 Nov; 13(11):1561-74; discussion 1574 passim. PubMed ID: 10581603
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy of melanoma].
Dummer R; Nestle FO; Burg G
Dtsch Med Wochenschr; 2000 Oct; 125(41):1240-2. PubMed ID: 11076264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
